OpenURL Connection Search

Select item for more details and to access through your institution.

Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
Published in:
2016
By:
- Cunlin Wang;
- Kane, Robert;
- Levenson, Mark;
- Kelman, Jeffrey;
- Wernecke, Michael;
- Joo-Yeon Lee;
- Kozlowski, Steven;
- Dekmezian, Carmen;
- Zhiwei Zhang;
- Thompson, Aliza;
- Smith, Kimberly;
- Yu-te Wu;
- Yuqin Wei;
- Chillarige, Yoganand;
- Qin Ryan;
- Worrall, Chris;
- MaCurdy, Thomas E.;
- Graham, David J.;
- Wang, Cunlin;
- Lee, Joo-Yeon
Publication type:
journal article
Endogenous and Exogenous Vasopressin during Hemodialysis.
Published in:
2009
By:
- Thompson, Aliza M.;
- Oliver, Juan A.
Publication type:
Editorial
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, p. 19, doi. 10.1111/dom.13453
By:
- Mol, Peter G. M.;
- Thompson, Aliza;
- Heerspink, Hiddo J. L.;
- Leufkens, Hubert G. M.
Publication type:
Article
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.
Published in:
JAMA: Journal of the American Medical Association, 2024, v. 331, n. 6, p. 491, doi. 10.1001/jama.2023.28239
By:
- Bird, Steven T.;
- Smith, Elizabeth R.;
- Gelperin, Kate;
- Jung, Tae Hyun;
- Thompson, Aliza;
- Kambhampati, Rekha;
- Lyu, Hai;
- Zhao, Henu;
- Zhao, Yueqin;
- Zhu, Yunfan;
- Easley, Olivia;
- Niak, Ali;
- Wernecke, Michael;
- Chillarige, Yoganand;
- Zemskova, Marina;
- Kelman, Jeffrey A.;
- Graham, David J.
Publication type:
Article
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.
Published in:
Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 285, doi. 10.1002/cpt.2151
By:
- Sahre, Martina D.;
- Milligan, Lauren;
- Madabushi, Rajanikanth;
- Graham, Richard A.;
- Reynolds, Kellie S.;
- Terzic, Andre;
- Benjamin, Jessica;
- Burckart, Gilbert J.;
- Huang, Shiew‐Mei;
- Schuck, Robert;
- Thompson, Aliza M.;
- Zineh, Issam
Publication type:
Article
Evaluating the Use of KIM‐1 in Drug Development and Research Following FDA Qualification.
Published in:
Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 6, p. 1175, doi. 10.1002/cpt.1093
By:
- Chen, Ru;
- Sanyal, Sarmistha;
- Thompson, Aliza;
- Ix, Joachim H.;
- Haskins, Kylie;
- Muldowney, Laurie;
- Amur, Shashi
Publication type:
Article
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective.
Published in:
Lupus, 2022, v. 31, n. 4, p. 424, doi. 10.1177/09612033221079771
By:
- Liu, Tao;
- Neuner, Rosemarie;
- Thompson, Aliza;
- Pottackal, Ginto;
- Petullo, David;
- Liu, Jiang;
- Nikolov, Nikolay;
- Sahajwalla, Chandrahas;
- Doddapaneni, Suresh;
- Chen, Jianmeng
Publication type:
Article

Found: 7

Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.

Endogenous and Exogenous Vasopressin during Hemodialysis.

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.

Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.

Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.

Evaluating the Use of KIM‐1 in Drug Development and Research Following FDA Qualification.

Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective.